FOLFOXIRI plus panitumumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FOLFOXIRI plus panitumumab, covering 2023-07-27 to 2023-07-27. Get the full timeline:
Most recent: Clinical Trial Update: FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer [Phase 2]